Cardiex Ltd
ASX:CDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aplab Ltd
BSE:517096
|
IN |
Cardiex Ltd
Common Stock
Cardiex Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cardiex Ltd
ASX:CDX
|
Common Stock
AU$102.9m
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
Somnomed Ltd
ASX:SOM
|
Common Stock
AU$112.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Cochlear Ltd
ASX:COH
|
Common Stock
AU$1.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
22%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Common Stock
AU$106.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Common Stock
AU$58.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Common Stock
AU$53.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Cardiex Ltd
Glance View
CardieX Ltd. is engaged in the designing, manufacturing, and marketing of medical devices for use in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm is focused on designing, manufacturing and marketing medical devices for use in cardiovascular health management. The company operates through its subsidiaries, including ATCOR and CONNEQT. The firm's ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the ATCOR.X brand, the Company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The firm's digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients' health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness and wellness parameters.
See Also
What is Cardiex Ltd's Common Stock?
Common Stock
102.9m
AUD
Based on the financial report for Jun 30, 2025, Cardiex Ltd's Common Stock amounts to 102.9m AUD.
What is Cardiex Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
11%
Over the last year, the Common Stock growth was 17%. The average annual Common Stock growth rates for Cardiex Ltd have been 15% over the past three years , 14% over the past five years , and 11% over the past ten years .
